Watton Corey's most recent trade in Zevra Therapeutics Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zevra Therapeutics Inc | Corey Watton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Corey Watton | Director | Purchase of securities on an exchange or from another person at price $ 7.84 per share. | 28 Mar 2025 | 300 | 1,800 (0%) | 0% | 7.8 | 2,352 | Common Stock |
| Zevra Therapeutics Inc | Watton Corey | Director | Purchase of securities on an exchange or from another person at price $ 7.92 per share. | 11 Oct 2024 | 500 | 1,500 (0%) | 0% | 7.9 | 3,958 | Common Stock |
| Zevra Therapeutics Inc | Corey Watton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 39,200 | 39,200 | - | - | Stock Option (right to buy) | |
| Zevra Therapeutics Inc | Corey Watton | Director | Purchase of securities on an exchange or from another person at price $ 5.95 per share. | 23 Jun 2023 | 275 | 1,000 (0%) | 0% | 5.9 | 1,636 | Common Stock |
| Zevra Therapeutics Inc | Corey Watton | Director | Purchase of securities on an exchange or from another person at price $ 5.52 per share. | 09 Jun 2023 | 325 | 725 (0%) | 0% | 5.5 | 1,794 | Common Stock |
| Zevra Therapeutics Inc | Corey Watton | Director | Purchase of securities on an exchange or from another person at price $ 5.10 per share. | 30 May 2023 | 400 | 400 (0%) | 0% | 5.1 | 2,042 | Common Stock |
| Zevra Therapeutics Inc | Corey Watton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 58,800 | 58,800 | - | - | Stock Option (right to buy) |